Subscribe To Our Newsletter
Subscribe To Our Newsletter

GFO Issue 79,   Article Number: 2

Share:

ROUND SEVEN DECISIONS

Sub-title :

Article Type:
News
     Author:
Bernard Rivers
     Date: 2007-11-12

ABSTRACT

ABSTRACT A detailed listing and analysis is provided of which Round 7 proposals have been approved.

Based on advise from the Technical Review Panel (TRP), the Board divided eligible Round 7 proposals into five Categories, as follows:
  • Category 1: Approved proposals requiring no or minor clarifications, which need to be provided within 8 weeks and then given a final approval by the TRP Chair and/or Vice-Chair.
  • Category 2: Proposals that are provisionally approved subject to the required clarifications being provided within a limited timeframe (6 weeks for the applicant to provide an initial detailed response to the TRP queries, and a further 3 months to obtain the final TRP approval should further clarifications be requested). The primary reviewer and secondary reviewer as well as TRP Chair and /or Vice-Chair need to give final approval.
  • Category 2B: Proposals that are treated as those in Category 2, but are regarded as being relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation.
  • Category 3: Proposals not approved in their present form, though applicants are encouraged to resubmit in some future Round following major revision.
  • Category 4: Proposals that are rejected, with applicants not encouraged to resubmit in any similar form.
The number of Round 7 grants per Category was as follows:
Table 5: Round 7 results by Category

Category

Number of proposals

Budget

Years 1-2

Budget

Years 1-5
Approved: Category 1 5 $53 m. $136 m.
Approved: Category 2 42 $657 m. $1,618 m.
Approved: Category 2B 26 $408 m. $1,009 m.

Subtotal: All Approved Proposals:

73

$1,119 m.

$2,762 m.
Not Approved: Category 3 74 $1,234 m. $2,939 m.
Not Approved: Category 4 3 $45 m. $113 m.

Subtotal: All Non-Approved Proposals:

77

$1,279 m.

$3,052 m.

Total: All Proposals

150

$2,397 m.

$5,814 m.

Round 7 results by applicant were as in Tables 6 and 7, below. Grants approved in Euros have had their values converted to US dollars at US $1.44092 per Euro, which is the UN official exchange rate that applied on 1 November.
Table 6: Round 7 results for country-level applicants

Country

Applicant

Decision

Component

Budget

Years 1-2

Budget

Years 1-5

Afghanistan

CCM

Approved: Category 2B

HIV/AIDS

$4,767,953

$10,077,515
Afghanistan CCM Not approved: Category 3 TB $16,761,247 $35,769,214

Angola

CCM

Approved: Category 2B

Malaria

$32,512,650

$78,470,624
Angola CCM Not approved: Category 3 TB $8,795,159 $16,323,433
Armenia CCM Not approved: Category 3 HIV/AIDS $8,387,015 $25,006,079
Armenia CCM Not approved: Category 3 TB $3,224,782 $7,909,924
Azerbaijan CCM Not approved: Category 3 Malaria $3,665,922 $6,321,003

Azerbaijan

CCM

Approved: Category 1

TB

$6,573,412

$23,591,627
Bangladesh CCM Not approved: Category 3 HIV/AIDS $21,082,381 $53,393,592
Bangladesh CCM Not approved: Category 3 Malaria $8,133,847 $19,596,925
Benin CCM Not approved: Category 3 HIV/AIDS $26,651,624 $63,423,329

Benin

CCM

Approved: Category 2B

Malaria

$13,385,305

$22,372,872

Bhutan

CCM

Approved: Category 2B

Malaria

$1,923,869

$2,932,772
Bolivia CCM Not approved: Category 3 Malaria $6,637,684 $11,810,260
Botswana CCM Not approved: Category 3 HIV/AIDS $18,105,960 $36,911,669

Burkina Faso

CCM

Approved: Category 2

Malaria

$17,442,345

$37,849,810
Burundi CCM Not approved: Category 3 HIV/AIDS $28,571,856 $84,090,448

Burundi

CCM

Approved: Category 2B

TB

$4,018,177

$10,940,597

Cambodia

CCM

Approved: Category 2

HIV/AIDS

$23,857,767

$46,693,979
Cambodia CCM Not approved: Category 3 TB $8,707,480 $21,732,519
Cameroon CCM Not approved: Category 3 HIV/AIDS $36,832,111 $81,489,056
Cameroon CCM Not approved: Category 3 Malaria $13,809,496 $57,156,479
Cameroon CCM Not approved: Category 3 TB $6,024,082 $11,068,029
Cape Verde CCM Not approved: Category 3 HIV/AIDS $6,311,201 $11,657,810

Central African Republic

CCM

Approved: Category 2

HIV/AIDS

$15,891,199

$43,999,379
Chad CCM Not approved: Category 3 HIV/AIDS $13,252,627 $30,838,419

Chad

CCM

Approved: Category 2

Malaria

$10,477,631

$27,497,966
China CCM Not approved: Category 3 HIV/AIDS $11,848,160 $21,636,832
China CCM Not approved: Category 3 Malaria $6,018,460 $11,957,891

China

CCM

Approved: Category 2B

TB

$5,313,264

$49,281,105
Colombia CCM Not approved: Category 3 HIV/AIDS $16,436,446 $37,759,055
Colombia CCM Not approved: Category 3 Malaria $30,555,478 $42,799,426
Colombia CCM Not approved: Category 3 TB $8,211,140 $15,941,101
Comoros CCM Not approved: Category 3 HIV/AIDS $1,354,097 $3,041,683
Comoros CCM Not approved: Category 3 Malaria $6,378,215 $14,722,607
Côte d'Ivoire CCM Not approved: Category 3 HIV/AIDS $48,843,161 $129,272,746

Cuba

CCM

Approved: Category 2B

TB

$5,455,745

$7,871,598

DR Congo

CCM

Approved: Category 2

HIV/AIDS

$22,675,189

$71,403,216
DR Congo CCM Not approved: Category 3 Malaria $19,701,102 $62,841,029
Dominican Republic CCM Not approved: Category 3 HIV/AIDS $23,050,027 $49,392,551

Dominican Republic

CCM

Approved: Category 2

TB

$5,650,022

$14,223,859
Ecuador CCM Not approved: Category 3 HIV/AIDS $12,917,989 $22,638,882

El Salvador

CCM

Approved: Category 2

HIV/AIDS

$10,618,394

$24,866,086
El Salvador CCM Not approved: Category 3 TB $3,204,120 $6,868,440
Eritrea CCM Not approved: Category 3 HIV/AIDS $5,278,780 $25,283,136

Ethiopia

CCM

Approved: Category 2B

HIV/AIDS

$64,959,699

$106,261,584
Ethiopia CCM Not approved: Category 3 Malaria $16,971,461 $99,572,846
Gaza Non-CCM (AMAN - NGO) Not approved: Category 3 TB $417,844 $417,844
Georgia CCM Not approved: Category 3 HIV/AIDS $18,350,889 $30,290,945
Ghana CCM Not approved: Category 3 Malaria $24,012,027 $114,757,578

Guinea Bissau

CCM

Approved: Category 2B

HIV/AIDS

$14,221,990

$44,154,072
Guinea Bissau CCM Not approved: Category 3 TB $3,672,828 $8,565,738
Guyana CCM Not approved: Category 3 HIV/AIDS $13,000,000 $37,000,000

Guyana

CCM

Approved: Category 2

Malaria

$1,844,002

$3,670,627

Haiti

CCM

Approved: Category 2

HIV/AIDS

$6,199,554

$15,000,000

India

CCM

Approved: Category 2

HIV/AIDS

$31,037,097

$88,173,118
Indonesia CCM Not approved: Category 3 HIV/AIDS $17,211,566 $57,306,841
Indonesia CCM Not approved: Category 3 Malaria $46,973,341 $60,873,895
Iran CCM Not approved: Category 3 HIV/AIDS $31,606,904 $48,933,717

Iran

CCM

Approved: Category 2B

Malaria

$5,832,844

$11,634,027

Iran

CCM

Approved: Category 2

TB

$14,249,166

$24,019,635

Jamaica

CCM

Approved: Category 2

HIV/AIDS

$15,219,930

$44,176,429

Kazakhstan

CCM

Approved: Category 2

HIV/AIDS

$12,964,117

$35,335,883

Kenya

CCM

Approved: Category 2

HIV/AIDS

$47,145,912

$132,269,783
Kenya CCM Not approved: Category 3 Malaria $17,983,932 $59,014,190

Kosovo

CCM

Approved: Category 1

HIV/AIDS

$2,433,080

$6,655,143

Kyrgyz Republic

CCM

Approved: Category 1

HIV/AIDS

$11,845,091

$28,209,191

Lao PDR

CCM

Approved: Category 2

Malaria

$7,058,890

$25,665,343

Lao PDR

CCM

Approved: Category 2

TB

$4,368,246

$10,905,922

Lesotho

CCM

Approved: Category 2

HIV/AIDS

$10,626,665

$33,264,808

Liberia

CCM

Approved: Category 2B

Malaria

$12,695,907

$37,380,198

Liberia

CCM

Approved: Category 2

TB

$6,408,872

$14,531,896

Macedonia

CCM

Approved: Category 2

HIV/AIDS

$4,245,932

$9,940,432
Madagascar CCM Not approved: Category 3 HIV/AIDS $10,097,290 $26,865,626

Madagascar

CCM

Approved: Category 2

Malaria

$26,095,449

$69,199,450

Malawi

CCM

Approved: Category 2

HIV/AIDS

$15,078,417

$36,025,380

Malawi

CCM

Approved: Category 2

Malaria

$34,839,182

$62,000,902

Malawi

CCM

Approved: Category 2

TB

$7,802,037

$17,961,859

Mali

CCM

Approved: Category 2B

TB

$4,412,826

$11,793,764

Mongolia

CCM

Approved: Category 2

HIV/AIDS

$1,440,102

$2,946,767

Mozambique

CCM

Approved: Category 2

TB

$6,735,303

$20,983,828

Nepal

CCM

Approved: Category 2

HIV/AIDS

$12,321,512

$36,620,119

Nepal

CCM

Approved: Category 2B

Malaria

$9,735,739

$25,757,233

Nepal

CCM

Approved: Category 2

TB

$4,740,974

$15,506,566
Nicaragua CCM Not approved: Category 3 HIV/AIDS $10,252,517 $21,082,833

Nicaragua

CCM

Approved: Category 2B

Malaria

$2,868,542

$5,729,504
Nicaragua CCM Not approved: Category 3 TB $2,333,609 $3,895,056

Niger

CCM

Approved: Category 2B

HIV/AIDS

$15,048,604

$43,011,335

Niger

CCM

Approved: Category 2B

Malaria

$31,686,047

$42,982,108
Nigeria CCM Not approved: Category 3 HIV/AIDS $38,263,602 $120,564,672
Nigeria CCM Not approved: Category 3 Malaria $124,669,413 $216,781,423
Nigeria CCM Not approved: Category 3 TB $24,273,085 $41,830,161
Pakistan CCM Not approved: Category 3 HIV/AIDS $17,411,393 $51,177,389

Pakistan

CCM

Approved: Category 2B

Malaria

$12,886,680

$21,557,705
Pakistan CCM Not approved: Category 3 TB $14,617,779 $25,247,993

Paraguay

CCM

Approved: Category 2B

TB

$2,149,206

$6,018,754
Russian Federation (Tomsk Oblast) Sub-CCM Not approved: Category 3 TB $7,459,895 $14,597,093

Rwanda

CCM

Approved: Category 2

HIV/AIDS

$63,978,048

$137,268,168

Sao Tome and Principe

CCM

Approved: Category 2

Malaria

$4,234,962

$8,698,492

Senegal

CCM

Approved: Category 2

Malaria

$30,487,664

$64,953,351

Senegal

CCM

Approved: Category 2B

TB

$4,494,276

$9,340,456

Sierra Leone

CCM

Approved: Category 2

Malaria

$10,011,250

$26,108,640

Sierra Leone

CCM

Approved: Category 2

TB

$4,340,048

$10,530,635
Solomon Islands CCM Not approved: Category 3 HIV/AIDS $1,967,144 $7,405,890
Solomon Islands CCM Not approved: Category 3 TB $760,169 $1,444,217

Somalia

Non-CCM

Approved: Category 2B

TB

$8,732,844

$29,353,798
South Africa CCM Not approved: Category 3 HIV/AIDS $28,129,471 $64,469,441
Sri Lanka CCM Not approved: Category 3 HIV/AIDS $6,417,592 $11,163,146
Sri Lanka CCM Not approved: Category 3 Malaria $8,548,350 $14,577,550
Sri Lanka CCM Not approved: Category 4 TB $3,102,868 $5,331,894
Sudan (Northern Sector) CCM Not approved: Category 3 HIV/AIDS $17,632,367 $25,081,867

Sudan (Northern Sector)

CCM

Approved: Category 2

Malaria

$38,296,873

$94,762,531
Sudan (Northern Sector) CCM Not approved: Category 3 TB $5,118,106 $11,250,611

Sudan (Southern Sector)

Sub-CCM

Approved: Category 2

Malaria

$35,008,693

$75,927,636

Sudan (Southern Sector)

Sub-CCM

Approved: Category 2

TB

$7,061,337

$17,598,282
Suriname CCM Not approved: Category 3 HIV/AIDS $4,759,904 $9,186,152

Suriname

CCM

Approved: Category 2

Malaria

$2,409,000

$4,232,000

Swaziland

CCM

Approved: Category 2

HIV/AIDS

$28,380,316

$81,866,490
Tanzania CCM Not approved: Category 3 HIV/AIDS $38,764,078 $103,554,555

Tanzania

CCM

Approved: Category 1

Malaria

$20,707,304

$52,545,829
Thailand CCM Not approved: Category 3 HIV/AIDS $23,383,543 $66,182,975

Thailand

CCM

Approved: Category 1

Malaria

$11,939,346

$24,689,670
Thailand CCM Not approved: Category 3 TB $6,491,515 $19,864,434

Timor-Leste

CCM

Approved: Category 2

Malaria

$6,866,605

$10,328,742

Timor-Leste

CCM

Approved: Category 2B

TB

$2,895,449

$7,011,931
Togo CCM Not approved: Category 3 HIV/AIDS $32,449,869 $84,200,275

Uganda

CCM

Approved: Category 2B

HIV/AIDS

$84,358,482

$268,800,980

Uganda

CCM

Approved: Category 2B

Malaria

$51,422,198

$125,571,990
Uganda CCM Not approved: Category 3 TB $2,416,931 $5,144,047
Ukraine CCM Not approved: Category 3 TB $52,827,422 $94,682,871
Uzbekistan CCM Not approved: Category 3 HIV/AIDS $7,154,490 $16,148,648
Uzbekistan CCM Not approved: Category 3 Malaria $2,213,257 $5,071,312
Uzbekistan CCM Not approved: Category 3 TB $9,538,632 $30,154,483
Vietnam CCM Not approved: Category 3 HIV/AIDS $13,154,988 $38,347,083

Vietnam

CCM

Approved: Category 2

Malaria

$11,926,329

$29,977,899

West Bank and Gaza

Non-CCM (UN Theme Group on HIV/AIDS)

Approved: Category 2B

HIV/AIDS

$5,014,330

$10,832,405

Yemen

CCM

Approved: Category 2

Malaria

$8,140,793

$27,862,946

Zambia

CCM

Approved: Category 2

Malaria

$18,003,233

$37,502,022
Zambia CCM Not approved: Category 3 TB $4,112,419 $24,959,034
Zanzibar CCM Not approved: Category 3 Malaria $5,961,504 $19,608,490
Zimbabwe CCM Not approved: Category 3 Malaria $26,225,739 $48,511,090
Zimbabwe CCM Not approved: Category 3 TB $11,247,899 $25,586,720

Table 7: Round 7 results for regional applicants

Region

Applicant

Decision

Component

Budget

Years 1-2

Budget

Years 1-5

Cook Islands, Micronesia, Kiribati, Marshall Islands, Nauru, Nieu, Palau, Samoa, Solomon Islands, Tonga, Tuvalu and Vanuatu

Regional Coordinating Mechanism (MCWP)

Approved: Category 2

HIV/AIDS

$10,710,982

$25,295,384

Cook Islands, Micronesia, Kiribati, Marshall Islands, Nauru, Nieu, Palau, Samoa, Solomon Islands, Tonga, Tuvalu and Vanuatu

Regional Coordinating Mechanism (MCWP)

Approved: Category 2B

TB

$5,684,067

$13,353,203
Bangladesh, India and Nepal Regional Org. (CARE) Not approved: Category 3 HIV/AIDS $23,893,276 $74,571,728
Bangladesh, India and Nepal Regional Org. (PSI) Not approved: Category 3 HIV/AIDS $11,058,387 $30,192,838
Bolivia, Colombia, Ecuador, Paraguay, Peru and Uruguay Regional Org. (REDLA+) Not approved: Category 3 HIV/AIDS $21,138,400 $50,059,500
Brunei, Cambodia, Indonesia, Lao PDR, Malaysia, Myanmar, Philippines, Singapore, Thailand and Vietnam Regional Org. (ASEAN) Not approved: Category 4 HIV/AIDS $34,807,826 $89,393,697
Cameroon, CAR, Congo, Gabon, Equatorial Guinea Regional Org. (CEEAC) Not approved: Category 4 HIV/AIDS $7,170,604 $18,109,467

El Salvador, Honduras, Nicaragua and Panama

Regional Org. (REDCA+)

Approved: Category 2B

HIV/AIDS

$1,849,200

$6,369,850
For further details on the approved proposals, see www.theglobalfund.org/en/about/board/sixteenth; for the non-approved proposals, see www.theglobalfund.org/en/apply/current/round7_notapproved. The full text of each Round 7 proposal is accessible at these links. An applicant may appeal the board's decision if the applicant submitted an eligible proposal for a particular component in both Round 6 and Round 7 and was not approved in either case. The appeal must show that the recommendation made by the TRP regarding the Round 7 proposal was based on a "significant and obvious" error. The appeal must be filed with the Secretariat no later than 28 days from when the applicant receives written notice from the Secretariat regarding the board's Round 7 decision. For further details regarding the appeals procedure, see www.theglobalfund.org/en/apply/proposals/appeals.

Publication Date: 2007-11-12


Tags:

Leave a reply

  • Comments

Your email address will not be published.

Aidspan

Categories*

Loading
Aidspan

Catégories*

Original text
Rate this translation
Your feedback will be used to help improve Google Translate